Needle-free Drug Delivery Technology Market by Product Type, Distribution Channel, End User 2024-2032

1
Global Needle-free Drug Delivery Technology
Market Research and Forecast Report 2024-2032

• Format PDFEXCEL

2023 IMARC All Rights Reserved
2
About IMARC Group

• International Market Analysis Research and
  Consulting Group is a leading adviser on
  management strategy and market research
  worldwide. We partner with clients in all regions
  and industry verticals to identify their
  highest-value opportunities, address their most
  critical challenges, and transform their
  businesses.
• IMARCs information products include major
  market, scientific, economic and technological
  developments for business leaders in
  pharmaceutical, industrial, and high technology
  organizations. Market forecasts and industry
  analysis for biotechnology, advanced materials,
  chemicals, food and beverage, travel and tourism,
  nanotechnology and novel processing methods are
  at the top of the companys expertise.
• IMARCs tailored approach combines unfathomable
  insight into the dynamics of companies and
  markets with close cooperation at all levels of
  the client organization. This ensures that our
  clients achieve unmatchable competitive
  advantage, build more proficient organizations,
  and secure lasting results.

3
Report Highlight and Description

• According to the latest report by IMARC Group,
  titled "Needle-free Drug Delivery Technology
  Market Global Industry Trends, Share, Size,
  Growth, Opportunity and Forecast
  2024-2032," the global needle-free drug delivery
  technology market size reached US 4.4 Billion in
  2023.
• Needle-free drug delivery technology is a medical
  innovation that allows for administering
  medications without using traditional hypodermic
  needles. It is designed to improve the patient's
  experience by eliminating the pain and anxiety
  associated with needle-based injections.
  Moreover, it aims to reduce the risks of
  needle-stick injuries and cross-contamination,
  which are significant concerns in healthcare
  settings.
• The technology employs various methods to
  introduce medications into the body, such as jet
  injection, which uses high pressure to propel a
  fine stream of medicine through the skin and into
  the underlying tissue. Needle-free drug delivery
  is particularly beneficial for children,
  geriatric population, and patients fearing
  needles. It is also valuable in mass vaccination
  campaigns where quick and efficient delivery of
  vaccines is essential.
• Request for a PDF sample of this report
  https//www.imarcgroup.com/needle-free-drug-delive
  ry-technology-market/requestsample

4
Report Description

• Global Needle-free Drug Delivery Technology
  Market Trends
• The increasing prevalence of chronic diseases,
  such as diabetes and cardiovascular conditions
  necessitating frequent medication administration
  is one of the major factors contributing to the
  market growth. Needle-free systems offer a more
  comfortable and less invasive alternative for
  patients who require regular injections. In
  addition to this, the widespread utilization of
  needle-free drug delivery technology as it
  addresses critical safety concerns in healthcare
  and enhances occupational safety is providing a
  thrust to the market growth. Traditional
  needle-based systems pose the risk of
  needle-stick injuries, which can lead to the
  transmission of infectious diseases among
  healthcare workers and patients. Along with this,
  the growing popularity of this technology, as it
  offers improved patient experience, especially in
  the pediatric and geriatric population, leading
  to better compliance with treatment regimens, is
  creating a positive outlook for the market
  growth. Moreover, the increasing applicability of
  needle-free systems in mass immunization
  programs, enabling faster delivery, which is
  particularly beneficial in urgent public health
  situations, such as pandemics or outbreaks, is
  providing an impetus to the market growth.
  Furthermore, the increasing regulatory support as
  governments and healthcare organizations
  increasingly recognize the benefits of
  needle-free drug delivery methods by allocating
  grants and funding for research and development
  (RD), thereby facilitating innovation and
  commercialization, is supporting the market
  growth.
• Looking forward, the market value is projected to
  reach US 6.7 Billion by 2032, expanding at a
  CAGR of 4.56 during 2024-2032.
• View Report TOC, Figures and Tables
  https//www.imarcgroup.com/needle-free-drug-delive
  ry-technology-market

5
Report Segmentation

• Product Insights
• Inhaler
• Jet Injector
• Novel Needles
• Transdermal Patch
• Others  
• Application Insights
• Vaccine Delivery
• Pain Management
• Insulin Delivery
• Others
• End User Insights
• Hospitals and Clinics

6
Report Segmentation

• Homecare Settings
• Research Laboratories
• Academics
• Others
• Regional Insights
• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa

7
Competitive Landscape with Key Players

• Akra Dermojet
• Antares Pharma Inc. (Halozyme Therapeutics Inc.)
• Crossject
• Mika Medical Co.
• PharmaJet
• Portal Instruments Inc.

8
Key Questions Answered in the Report
9
Table of Contents

• 1    Preface2    Scope and Methodology    2.1  
   Objectives of the Study    2.2  
   Stakeholders    2.3    Data Sources       
  2.3.1    Primary Sources        2.3.2  
   Secondary Sources    2.4    Market Estimation 
        2.4.1    Bottom-Up Approach        2.4.2  
   Top-Down Approach    2.5    Forecasting
  Methodology3    Executive Summary4  
   Introduction    4.1    Overview    4.2    Key
  Industry Trends5    Global Needle-free Drug
  Delivery Technology Market    5.1    Market
  Overview    5.2    Market Performance    5.3  
   Impact of COVID-19  5.4    Market Forecast
• 6     Market Breakup by Product
•   6.1    Inhaler    6.1.1 Market Trends   
     6.1.2 Market Forecast    6.2 Jet
  Injector    6.2.1  Market Trends       6.2.2
  Market Forecast    6.3 Novel Needles   
  6.3.1 Market Trends       6.3.2 Market
  Forecast       

10
Table of Contents

• 6.4 Transdermal Patch
• 6.4.1 Market Trends
• 6.4.2 Market Forecast
• 6.5 Others
• 6.5.1 Market Trends
• 6.5.2 Market Forecast
• 7  Market Breakup by Application
• 7.1 Vaccine Delivery
• 7.1.1 Market Trends
• 7.1.2 Market Forecast
• 7.2 Pain Management
• 7.2.1 Market Trends
• 7.2.2 Market Forecast
• 7.3 Insulin Delivery
• 7.3.1 Market Trends
• 7.3.2 Market Forecast
• 7.4 Others
• 7.4.1 Market Trends
• 7.4.2 Market Forecast

11
Disclaimer

• 2023 IMARC All Rights Reserved
• This Publication and all its contents unless
  otherwise mentioned are copyrighted in the name
  of International Market Analysis Research and
  Consulting (IMARC). No part of this publication
  may be reproduced, repackaged, redistributed or
  resold in whole or in any part. The publication
  may also not be used in any form or by and means
  graphic electronic or mechanical, including
  photocopying, recording, taping or by information
  storage or retrieval, or by any other form,
  without the express consent of International
  Market Analysis Research and Consulting (IMARC).
• Disclaimer All contents and data of this
  publication, including forecasts, data analysis
  and opinion have been based on information and
  sources believed to be accurate and reliable at
  the time of publishing. International Market
  Analysis Research and Consulting makes no
  representation of warranty of any kind as to the
  accuracy or completeness of any Information
  provided. IMARC accepts no liability whatsoever
  for any loss or damage resulting from opinion,
  errors or inaccuracies if any found this
  publication.
• IMARC, IMARC Group and Global Therapy Insight
  Series are registered trademarks of International
  Market Analysis Research and Consulting. All
  other trademarks used in this publication are
  registered trademarks of their respective
  companies.

12
Contact Us
Visit us at
https//www.imarcgroup.com
TELEPHONE [phone] E-MAIL
sales_at_imarcgroup.com